Form UPLOAD - SEC-generated letter:
SEC Accession No. 0000000000-21-006167
Filing Date
2021-05-14
Accepted
2021-05-14 14:30:06
Documents
2

Document Format Files

Seq Description Document Type Size
1 filename1.pdf LETTER 27648
2 filename2.txt TEXT-EXTRACT 1459
  Complete submission text file 0000000000-21-006167.txt   40178
Mailing Address 9900 CAVENDISH BLVD., SUITE 306 ST. LAURENT QUEBEC CANADA A8 H4M 2V2
Business Address 9900 CAVENDISH BLVD., SUITE 306 ST. LAURENT QUEBEC CANADA A8 H4M 2V2 1-800-936-9669
NYMOX PHARMACEUTICAL CORP (Filed for) CIK: 0001018735 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: UPLOAD
SIC: 2835 In Vitro & In Vivo Diagnostic Substances